glutathione ros depletion induces oxidative injury and apoptosis via TRPM2 channel activation in renal collecting duct cells Mitochondrial reactive oxygen species generation

International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription

10.3109/08923973.2013.782318 172 SolV.PunzonV.FresnoM

Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium

it has the strongest evidence for GI repair including ulcers, IBD models, and gut barrier integrity Tendon-to-bone healing multiple studies show accelerated tendon repair and reattachment Neuroprotection interaction with dopaminergic and serotonergic systems Oral administration BPC-157 survives stomach acid, making it the only healing peptide with oral bioavailability Where TB-500 Has Stronger Evidence Cardiac tissue repair parent molecule (TB-4) shown to activate epicardial progenitor cells in Nature publications Muscle regeneration superior satellite cell activation and muscle fiber repair Wound healing extensive dermal wound closure data Anti-fibrotic effects reduces excessive scar tissue formation across multiple tissue types Corneal healing significant clinical research in eye injury repair Where Both Are Strong Tendon & ligament repair both show significant benefit through different pathways Anti-inflammatory effects both reduce pro-inflammatory cytokines Angiogenesis both promote new blood vessel formation (different pathways) Dosing Comparison For research and educational discussion only